Biopixlar ready to face key challenges for bioprinting
As the world of bioprinting moves from concepts to actual biological applications, the performance requirements put on emerging…
Fluicell at BPS 2020
Fluicell is an innovative biotech company with the ambition to create new opportunities for life science. This year,…
05
Feb
2020
Fluicell welcomes Klaudia Małgorzata Jurczak
Starting in January 2020, Klaudia Małgorzata Jurczak is joining Fluicell to do her Master’s thesis work. Klaudia has…
04
Feb
2020
NMDAR enhancer with benefits for Alzheimer´s disease
NMDA receptors play subunit-specific roles in synaptic function with connections to neuropsychiatric and neurodegenerative disorders. In the study…
28
Jan
2020
Student visit at Fluicell
Yesterday we had the great pleasure of receiving a student visit from SBE Student Chapter Chalmers. It was…
21
Jan
2020
Promising new insights into ion channel function
Researchers at Genentech Inc. have studied the structure and function of voltage-gated sodium channels, using Dynaflow Resolve to…
17
Dec
2019
IMPRESSIVE MEDIA INTEREST IN BIOPIXLAR
Biopixlar, described as a groundbreaking bioprinter with great possibilities for medical research and with a unique design, has…
26
Nov
2019
We have great customers
We would like to thank the Roland Malli’s Lab from Medical University of Graz for their nice review…
13
Nov
2019
Fluicell featured in TechRadar
Please, check the article about Biopixlar published today in TechRadar! This expensive 3D bioprinter is controlled by a…
08
Nov
2019